Avalia Immunotherapies
Kelburn
About Avalia Immunotherapies
Avalia Immunotherapies is a developer of immune therapies that support the treatment and prevention of infectious disease and cancer.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $624.7K
- Funding stage: Seed
- Last round: Grant (Oct 2020)
- Website: avaliaimmunotherapies.com
- Phone: +64 27-349-9777
Industries & Categories
Health Care, Medical, Pharmaceutical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/avalia-immunotherapies-203813 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.